BridgeBio Oncology Therapeutics, Inc. (NASDAQ:BBOT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bihua Chen Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Helix Acquisition Corp. III (Chairperson and CEO, Director · Since at least Jan 22, 2026); Biomea Fusion, Inc. (Director · Since at least Apr 15, 2021); Erasca, Inc. (Director · Jul 15, 2021 – Jun 22, 2023 · Past); Monte Rosa Therapeutics, Inc. (Director · Jun 23, 2021 – Jun 23, 2021 · Past); Verve Therapeutics Inc (Director · Jun 16, 2021 – Jun 21, 2021 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Apr 27, 2021 · Past); Design Therapeutics, Inc. (Director · Mar 25, 2021 – Mar 25, 2021 · Past); Prometheus Biosciences Inc (Director · Mar 11, 2021 – Mar 11, 2021 · Past); BioAtla, Inc. (Director · Dec 15, 2020 – Dec 18, 2020 · Past); Olema Pharmaceuticals, Inc. (Director · Nov 18, 2020 – Nov 23, 2020 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); MoonLake Immunotherapeutics (CEO and Chairman, Director · Oct 19, 2020 – Oct 22, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Jun 30, 2020 · Past); Avidity Biosciences, Inc (Director · Jun 11, 2020 – Jun 16, 2020 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Aug 12, 2019 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Oct 31, 2018 · Past); Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jul 18, 2018 · Past); Kezar Life Sciences, Inc. (Director · Jun 20, 2018 – Jun 25, 2018 · Past); Kiniksa Pharmaceuticals International, plc (Director · May 23, 2018 – May 29, 2018 · Past); Apellis Pharmaceuticals, Inc. (Director · Nov 8, 2017 – Nov 13, 2017 · Past); Kineta Inc. (Director · Nov 3, 2016 – Dec 14, 2017 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 1, 2016 · Past); Cellectar Biosciences, Inc. (Director · Aug 15, 2014 – Aug 15, 2014 · Past) | Director · Since at least Feb 8, 2024 |
| John Schmid Other companies: BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past); Neos Therapeutics Inc (Director · Jul 2, 2018 – Mar 19, 2021 · Past) | Director · Feb 8, 2024 – Feb 8, 2024 · Past |
| Mark McKenna Other companies: Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Jul 16, 2024); Spyre Therapeutics, Inc. (Board Member · Since at least Feb 1, 2024); Apogee Therapeutics, Inc. (Director · Since at least Aug 17, 2023); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); Prometheus Biosciences Inc (Chairman, President and CEO, Director · Mar 11, 2021 – Jun 16, 2023 · Past); Bausch Health Companies Inc. (President, Salix · Aug 2, 2018 – Aug 19, 2019 · Past) | Director · Feb 8, 2024 – Feb 8, 2024 · Past |
| Jake Bauer Other companies: Immunovant, Inc. (Director · Since at least Apr 18, 2025); Enliven Therapeutics, Inc. (Chairman of the Board of Directors · Since at least Feb 23, 2023); ARYA Sciences Acquisition Corp V (Director · Jul 12, 2021 – Jul 12, 2021 · Past); Cerevel Therapeutics Holdings Inc (Director · Jun 4, 2020 – Jun 4, 2020 · Past); MyoKardia Inc (Chief Business Officer · Oct 28, 2015 – Nov 17, 2020 · Past) | Director · Since at least Aug 11, 2025 |
| Frank McCormick Other companies: BridgeBio Pharma, Inc. (Director · Since at least Jun 27, 2019); Olema Pharmaceuticals, Inc. (Director · Sep 18, 2020 – Nov 23, 2020 · Past); Aduro Biotech Inc (Director · Apr 14, 2015 – Jun 6, 2018 · Past); Exelixis, Inc. (Director · May 2, 2006 – Dec 6, 2013 · Past) | Director · Since at least Aug 11, 2025 |
| Neil Kumar Other companies: Maze Therapeutics, Inc. (Director · Since at least Mar 27, 2026); BridgeBio Pharma, Inc. (Chief Executive Officer, Director · Since at least Jun 27, 2019); Eidos Therapeutics Inc (Chief Executive Officer, Director · Jun 19, 2018 – Jul 3, 2019 · Past) | Executive Chairman · Since at least Aug 11, 2025 |
| Praveen Tipirneni Other companies: Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Panacea Acquisition II Corp (Director · Apr 6, 2021 – Apr 6, 2021 · Past); Morphic Holding Inc (President and CEO, Director · Jun 26, 2019 – Aug 16, 2024 · Past) | Non-Executive Director · Since at least Aug 11, 2025 |
| Caleb Tripp Other companies: Helix Acquisition Corp. III (CFO & COO · Since at least Jan 22, 2026); BridgeBio Pharma, Inc. (Chief Financial Officer · Feb 28, 2025 – Nov 4, 2026 · Past) | Chief Financial Officer · Since at least Feb 8, 2024 |
| Michelle Doig Other companies: Nuvation Bio Inc. (Director · Feb 10, 2021 – Feb 10, 2021 · Past); Omega Alpha SPAC (President, Director · Jan 6, 2021 – Jan 6, 2021 · Past) | Director · Since at least Aug 11, 2025 |
| Uneek Mehra Other companies: 4D Molecular Therapeutics, Inc. (See Remarks · Sep 22, 2023 – Mar 6, 2025 · Past); Myovant Sciences Ltd (Principal Financial Officer · Sep 7, 2021 – Mar 10, 2023 · Past) | Chief Financial Officer · Since at least Aug 11, 2025 |
| Jake Bauer Other companies: Immunovant, Inc. (Board Member · Since at least Apr 9, 2026) | Chairman · Since at least Aug 11, 2025 |
| Marc Cobo Other companies: Tricida Inc (SVP, Finance & CAO · Jun 29, 2020 – Sep 10, 2020 · Past) | Vice President of Finance and Controller · Since at least Apr 21, 2026 |
| Nebojsa Obradovic Other companies: Helix Acquisition Corp. III (Chief Legal Officer · Since at least Jan 22, 2026) | Chief Legal Officer · Since at least Feb 8, 2024 |
| Pedro J. Beltran Other companies: BridgeBio Pharma, Inc. (Chief Executive Officer, Idan Elmelech as Chief Operating Officer · Since Apr 20, 2026) | Chief Executive Officer · Since at least Aug 11, 2025 |
| Yong Ben Other companies: Corbus Pharmaceuticals Holdings, Inc. (Director · Since at least Mar 6, 2023) | Chief Medical and Development Officer · Since at least Aug 11, 2025 |
| Aaron Chan | Vice President, Legal · Since at least Nov 4, 2026 |
| Albert A Holman III | Director · Feb 8, 2025 – Feb 8, 2025 · Past |
| Bin Wang | Senior Vice President, Drug Discovery · Since at least Nov 4, 2026 |
| Chunmei Ji | Vice President, Head of Toxicology · Since at least Nov 4, 2026 |
| Daniel Watson | Senior Vice President, Chemistry, Manufacturing, and Controls · Since at least Nov 4, 2026 |
| Eli M Wallace | Chief Executive Officer, Director · Since at least Aug 11, 2025 |
| Foster Gonsalves | Vice President, Early Development · Since at least Nov 4, 2026 |
| Frank McCormick | Cofounder, Non-Executive Director · Since at least Mar 6, 2026 |
| Heather Armstrong | Head of Investor Relations BBOT · Since at least May 12, 2026 |
| Hua Gong | Vice President, Translational Medicine · Since at least Nov 4, 2026 |
| Idan Elmelech | Chief Operating Officer · Since at least Feb 28, 2025 |
| Joon Whan Rhee | Vice President, Clinical Development · Since at least Nov 4, 2026 |
| Kerstin Sinkevicius | Vice President, Pharmacology · Since at least Oct 13, 2025 |
| Peter F. Lebowitz | Director · Since at least Mar 24, 2026 |
| Raymond Kelleher | Director · Since at least Aug 11, 2025 |
| Rui Xu | Senior Vice President, Drug Discovery · Since at least Nov 4, 2026 |
| Sunyoung Lee | Vice President, Regulatory Affairs · Since at least Nov 4, 2026 |